SK280400B6 - Deriváty 1,3-dihydro-2h-pyrolo[2,3-b]chinolin-2-ón - Google Patents

Deriváty 1,3-dihydro-2h-pyrolo[2,3-b]chinolin-2-ón Download PDF

Info

Publication number
SK280400B6
SK280400B6 SK1596-95A SK159695A SK280400B6 SK 280400 B6 SK280400 B6 SK 280400B6 SK 159695 A SK159695 A SK 159695A SK 280400 B6 SK280400 B6 SK 280400B6
Authority
SK
Slovakia
Prior art keywords
formula
pyrrolo
quinolin
dihydro
alkyl
Prior art date
Application number
SK1596-95A
Other languages
English (en)
Slovak (sk)
Other versions
SK159695A3 (en
Inventor
Eddy J. E. Freyne
Alfons H. M. Raeymaekers
Original Assignee
Janssen Pharmaceutica N. V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N. V. filed Critical Janssen Pharmaceutica N. V.
Publication of SK159695A3 publication Critical patent/SK159695A3/sk
Publication of SK280400B6 publication Critical patent/SK280400B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
SK1596-95A 1993-06-21 1994-06-15 Deriváty 1,3-dihydro-2h-pyrolo[2,3-b]chinolin-2-ón SK280400B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP93201771 1993-06-21
PCT/EP1994/001960 WO1995000512A1 (en) 1993-06-21 1994-06-15 Positive inotropic and lusitropic pyrroloquinolinone derivatives

Publications (2)

Publication Number Publication Date
SK159695A3 SK159695A3 (en) 1997-01-08
SK280400B6 true SK280400B6 (sk) 2000-01-18

Family

ID=8213908

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1596-95A SK280400B6 (sk) 1993-06-21 1994-06-15 Deriváty 1,3-dihydro-2h-pyrolo[2,3-b]chinolin-2-ón

Country Status (29)

Country Link
US (1) US5602134A (lv)
EP (1) EP0707586B1 (lv)
JP (1) JP2812804B2 (lv)
KR (1) KR0181560B1 (lv)
CN (1) CN1043765C (lv)
AT (1) ATE171179T1 (lv)
AU (1) AU679077B2 (lv)
BG (1) BG62171B1 (lv)
BR (1) BR9406899A (lv)
CA (1) CA2163122C (lv)
CZ (1) CZ284350B6 (lv)
DE (1) DE69413398T2 (lv)
FI (1) FI109124B (lv)
HU (1) HU220670B1 (lv)
IL (1) IL110055A (lv)
LT (1) LT3447B (lv)
LV (1) LV11545B (lv)
MY (1) MY110751A (lv)
NO (1) NO305366B1 (lv)
OA (1) OA10202A (lv)
PH (1) PH31308A (lv)
PL (1) PL176783B1 (lv)
RU (1) RU2129554C1 (lv)
SG (1) SG49717A1 (lv)
SI (1) SI9420041A (lv)
SK (1) SK280400B6 (lv)
TW (1) TW593317B (lv)
WO (1) WO1995000512A1 (lv)
ZA (1) ZA944382B (lv)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7208497B2 (en) 2001-07-02 2007-04-24 Novo Nordisk A/S Substituted piperazines and diazepanes
ATE450508T1 (de) * 2001-09-14 2009-12-15 High Point Pharmaceuticals Llc Substituierte piperidinen mit selektiver bindungsfähigkeit zu histamin h3-rezeptoren
US20030186963A1 (en) 2001-09-14 2003-10-02 Dorwald Florencio Zaragoza Substituted piperidines
TWI498115B (zh) * 2007-12-27 2015-09-01 Daiichi Sankyo Co Ltd 咪唑羰基化合物
GB0808953D0 (en) * 2008-05-16 2008-06-25 Shire Llc substituted quinazolines
GB0808944D0 (en) * 2008-05-16 2008-06-25 Shire Llc Substituted quinazolines
RU2457208C2 (ru) * 2009-07-06 2012-07-27 Государственное образовательное учреждение высшего профессионального образования "Пермская государственная фармацевтическая академия Федерального агентства по здравоохранению и социальному развитию" (ГОУ ВПО "ПГФА Росздрава") 1H-ПИРРОЛО[3,4-b]ХИНОЛИН-3,9(2H,4H)-ДИОНЫ, ОБЛАДАЮЩИЕ ПРОТИВОТУБЕРКУЛЕЗНОЙ АКТИВНОСТЬЮ, И СПОСОБ ИХ ПОЛУЧЕНИЯ

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4775674A (en) 1986-05-23 1988-10-04 Bristol-Myers Company Imidazoquinolinylether derivatives useful as phosphodiesterase and blood aggregation inhibitors
NZ234186A (en) * 1989-07-07 1991-10-25 Janssen Pharmaceutica Nv Imidazo quinazolin-one derivatives and pharmaceutical compositions
CN1030196C (zh) * 1989-07-07 1995-11-01 詹森药业有限公司 增强收缩力和舒张力的-二氢咪唑并喹唑啉酮衍生物的制备方法
US5220023A (en) * 1989-07-18 1993-06-15 Janssen Pharmaceutica N.V. Glycine derivatives
US4943573A (en) 1989-11-01 1990-07-24 Bristol-Myers Squibb Company Imidazo[4,5-b]quinolinyloxyalkanoic acid amides with enhanced water solubility
US5196428A (en) * 1992-04-03 1993-03-23 Bristol-Myers Squibb Company Imidazo[4,5-b]qinolinyl oxy alkyl ureas

Also Published As

Publication number Publication date
ZA944382B (en) 1995-12-20
KR0181560B1 (ko) 1999-05-01
PH31308A (en) 1998-07-06
IL110055A0 (en) 1994-10-07
DE69413398T2 (de) 1999-04-15
TW593317B (en) 2004-06-21
ATE171179T1 (de) 1998-10-15
JP2812804B2 (ja) 1998-10-22
JPH09500108A (ja) 1997-01-07
RU2129554C1 (ru) 1999-04-27
CA2163122C (en) 2005-06-14
CN1125945A (zh) 1996-07-03
PL176783B1 (pl) 1999-07-30
CZ284350B6 (cs) 1998-10-14
WO1995000512A1 (en) 1995-01-05
US5602134A (en) 1997-02-11
HUT72090A (en) 1996-03-28
CN1043765C (zh) 1999-06-23
SG49717A1 (en) 1998-06-15
PL312252A1 (en) 1996-04-01
BG62171B1 (bg) 1999-04-30
FI956143A0 (fi) 1995-12-20
AU7000894A (en) 1995-01-17
LV11545A (lv) 1996-10-20
BR9406899A (pt) 1996-04-09
MY110751A (en) 1999-02-27
LV11545B (en) 1997-08-20
LT3447B (en) 1995-10-25
DE69413398D1 (de) 1998-10-22
IL110055A (en) 1997-09-30
FI109124B (fi) 2002-05-31
CA2163122A1 (en) 1995-01-05
NO955028D0 (no) 1995-12-12
BG100209A (bg) 1996-07-31
HU220670B1 (hu) 2002-04-29
EP0707586A1 (en) 1996-04-24
CZ336695A3 (en) 1996-03-13
NO305366B1 (no) 1999-05-18
HU9501970D0 (en) 1995-09-28
NO955028L (no) 1995-12-12
FI956143A (fi) 1995-12-20
SK159695A3 (en) 1997-01-08
OA10202A (en) 1996-12-18
EP0707586B1 (en) 1998-09-16
AU679077B2 (en) 1997-06-19
SI9420041A (en) 1996-08-31
LTIP1960A (en) 1995-01-31

Similar Documents

Publication Publication Date Title
US4943573A (en) Imidazo[4,5-b]quinolinyloxyalkanoic acid amides with enhanced water solubility
US7714009B2 (en) Nitrogen-containing fused heterocyclic compounds
FI66372C (fi) Foerfarande foer framstaellning av farmakologiskt verkande i 5- eller 6-staellning med en pyridazinonring substituerade besimidazoler
EP0722936A1 (en) Fused pyridazine compound
PL169415B1 (pl) metylo-6-okso-3-pirydazynylo)fenylo]hydrazono]propanodinitrylu PL PL PL PL PL PL PL PL
NO173653B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 6-benzoksazinyl- og 6-benzotiazinyl-2,3,4,5-tetrahydropyridazin-3-oner
SK280400B6 (sk) Deriváty 1,3-dihydro-2h-pyrolo[2,3-b]chinolin-2-ón
EP1641795B1 (en) Triaza- and tetraaza-anthracenedione derivatives, their preparation and their use as pharmaceuticals
EP0227451A2 (en) 5,6-Dialkoxy-4-imino-2 (1H)quinazolinone derivatives
Monge et al. New 5H-pyridazino [4, 5-b] indole derivatives. Synthesis and studies as inhibitors of blood platelet aggregation and inotropics
US5252567A (en) Diazine derivatives
US5030646A (en) Novel tricyclic indole compound
EP0697407B1 (en) Pyrimidinedione derivatives and antiarrhythmic compositions containing same
NZ267647A (en) Pyrroloquinolinone derivatives, medicaments thereof and pyrrole intermediates
MXPA94004666A (en) Inotropic and positive lusitropic derivatives of pirroloquinolin
US4701453A (en) Substituted indeno-pyridazinones
JP2003516990A (ja) 経口で活性のあるエラスターゼ阻害剤としてのサッカリン誘導体
JPH03261773A (ja) 新規ヘテロ環式化合物及びその製造方法
JP2000239277A (ja) イミダゾキナゾリン誘導体